Re: OSR#1 is not a dietary supplement but a toxic, unapproved drug with serious pote

[Guest guest]

Sadly, this is one of the supplements my son was on. Sold to us a mild mild

chelator for his heavy metal load. $450.00

>

> latimes.com/news/health/sns-health-illegal-autism-therapy,0,747838.story

>

> latimes.com

> FDA: Autism 'Therapy' Illegal

> OSR#1 is not a dietary supplement but a toxic, unapproved drug with serious

potential side effects, the U.S. Food and Drug Administration warns.

> Trine Tsouderos

>

> Tribune reporter

>

> 5:18 PM PDT, June 23, 2010

>

> Advertisement

>

> A product promoted to parents of children with autism is not a harmless

dietary supplement, as claimed, but a toxic unapproved drug that lacks adequate

warnings about potential side effects, including hair loss and abnormalities of

the pancreas, the U.S. Food and Drug Administration has warned in a letter to

its maker.

>

> The FDA's June 17 letter to Boyd Haley, a retired Kentucky chemist and hero to

the autism recovery movement, details five violations of the Federal Food, Drug

and Cosmetic Act related to his product, OSR#1. Failing to correct such

violations can result in fines, seizure of products and even criminal

prosecution.

>

> The Tribune in January reported that the compound, sold as OSR#1, had been

developed to treat mining wastewater, and that it had not undergone rigorous

testing to ensure it is safe and effective. The report was part of an

investigation into unproven autism therapies offered by health providers who say

they can reverse the disorder.

>

> Haley did not reply to repeated requests for an interview Wednesday. An FDA

spokeswoman said the agency has not received any communication from Haley, who

has 15 working days from the date of the letter to respond.

>

> Last year, Haley told the Tribune: " I am not breaking any law. … We are being

very, very careful. "

>

> The Web site for Haley's company, Lexington, Ky.-based CTI Science, on

Wednesday was still promoting OSR#1 as " a toxicity free, lipid soluble

antioxidant dietary supplement, " and a reporter was able to order 30

100-milligram capsules of OSR#1 for $60 through an online pharmacy.

>

> In the interview last year, Haley called the product " a food " that is " totally

without toxicity. " Haley said the compound had been tested on rats, and a food

safety study was conducted on 10 people. Asked to provide documentation of the

research, he stopped communicating with the Tribune.

>

> The FDA letter lists side effects recorded during Haley's animal studies:

" soiling of the anogenital area, alopecia (hair loss) on the lower trunk, back

and legs, a dark substance on lower trunk and anogenital area, abnormalities of

the pancreas " and a rapid increase in normal cells contained in the lymph nodes.

>

> " It would be hard to imagine anything worse, " said Ellen Silbergeld, an expert

in environmental health who is studying mercury and autism at s Hopkins

University's Bloomberg School of Public Health. " An industrial chemical known to

be toxic — his own incomplete testing indicates it is toxic. It has no record of

any therapeutic aspect of it, and it is being marketed for use in children. "

>

> OSR#1 has been promoted on autism Web sites including Age of Autism, where

Managing Editor Kim Stagliano wrote of sprinkling the white powder on her three

daughters' breakfast sandwiches and orange juice. " We've seen some nice 'Wows!'

from OSR, " she wrote.

>

> In an e-mail, Stagliano wrote that she continues to support Haley, a regular

speaker at autism recovery conferences. " Having met Dr. Haley at conferences,

including Autism One in Chicago last month, I continue to trust his science, "

she wrote on Wednesday. " I'm sure CTI Science will address the letter

appropriately. "

>

> Pharmacologist Dr. Arthur Grollman, director of the Laboratory for Chemical

Biology at State University of New York at Stony Brook, said it is clear from

the product's chemical structure that it is a " powerful chelator, " a compound

that binds to heavy metals such as mercury.

>

> The FDA has approved several chelators as drugs to treat heavy-metal

poisoning. Some doctors also use the drugs — which carry significant risks — to

treat children with autism on the scientifically unfounded idea that their

disorder is linked to toxic metals.

>

> The chemical being sold as OSR#1 is part of a family of chelators originally

developed for industrial purposes, according to a U.S. patent issued in 2003 and

assigned to the University of Kentucky Research Foundation.

>

> The magazine Medical Veritas in 2006 reported that Haley said he was

interested in developing better chelators for people. " We've made compounds that

.... work tremendously " in a test tube, he was quoted as saying. " However, we've

got to show that they're not toxic. That costs a lot of money and it's very

difficult to do, you have to have the right facilities. That's where we're hung

up right now, the question is, 'How do we get somebody to do these studies?' "

>

> In January 2008, Haley changed the name of his company from Chelator

Technologies Inc. to CTI Science Inc., records show. Less than a month later, he

notified the FDA he would be introducing the compound as a new dietary

ingredient, a designation rejected by the FDA in its recent letter.

>

> " Because OSR#1 does not bear or contain a dietary ingredient as defined (by

the food and drug act), this product does not qualify as a dietary supplement, "

the letter states.

>

> Instead, according to the letter, it is a new drug. Winning FDA approval

requires proof of safety and efficacy through clinical trials, a process that

can cost hundreds of millions of dollars and take many years.

>

> " Anything might be a cure for anything else, but the odds are it will do

nothing and it might very well be toxic, " said Mailman, a

neuropharmacologist at Penn State University. " That is why drug discovery and

development is so expensive. "

>

> Silbergeld said the product represents a clear example of endangerment of

public health and that the FDA should stop CTI Science from selling it

immediately. She drew a comparison to a city's drinking water system: If

contamination is found, she said, " they turn off the pumps. "

>

> " They don't have to engage in a long discussion with you, " Silbergeld said.

" It would be hard to imagine a more clear example of immediate endangerment of

public health. Turn off the pump. "

>

> , Chicago Tribune

>

[Guest guest]

Age of Autism and DAN! Moms everywhere are up in arms about this article. They

cry foul play and scapegoating. They worry about giving medications to their

child but do not think twice about giving this to their kids. Where has the

common sense gone??

-

>

> >

>

> > latimes.com/news/health/sns-health-illegal-autism-therapy,0,747838.story

>

> >

>

> > latimes.com

>

> > FDA: Autism 'Therapy' Illegal

>

> > OSR#1 is not a dietary supplement but a toxic, unapproved drug with serious

potential side effects, the U.S. Food and Drug Administration warns.

>

> > Trine Tsouderos

>

> >

>

> > Tribune reporter

>

> >

>

> > 5:18 PM PDT, June 23, 2010

>

> >

>

> > Advertisement

>

> >

>

> > A product promoted to parents of children with autism is not a harmless

dietary supplement, as claimed, but a toxic unapproved drug that lacks adequate

warnings about potential side effects, including hair loss and abnormalities of

the pancreas, the U.S. Food and Drug Administration has warned in a letter to

its maker.

>

> >

>

> > The FDA's June 17 letter to Boyd Haley, a retired Kentucky chemist and hero

to the autism recovery movement, details five violations of the Federal Food,

Drug and Cosmetic Act related to his product, OSR#1. Failing to correct such

violations can result in fines, seizure of products and even criminal

prosecution.

>

> >

>

> > The Tribune in January reported that the compound, sold as OSR#1, had been

developed to treat mining wastewater, and that it had not undergone rigorous

testing to ensure it is safe and effective. The report was part of an

investigation into unproven autism therapies offered by health providers who say

they can reverse the disorder.

>

> >

>

> > Haley did not reply to repeated requests for an interview Wednesday. An FDA

spokeswoman said the agency has not received any communication from Haley, who

has 15 working days from the date of the letter to respond.

>

> >

>

> > Last year, Haley told the Tribune: " I am not breaking any law. … We are

being very, very careful. "

>

> >

>

> > The Web site for Haley's company, Lexington, Ky.-based CTI Science, on

Wednesday was still promoting OSR#1 as " a toxicity free, lipid soluble

antioxidant dietary supplement, " and a reporter was able to order 30

100-milligram capsules of OSR#1 for $60 through an online pharmacy.

>

> >

>

> > In the interview last year, Haley called the product " a food " that is

" totally without toxicity. " Haley said the compound had been tested on rats, and

a food safety study was conducted on 10 people. Asked to provide documentation

of the research, he stopped communicating with the Tribune.

>

> >

>

> > The FDA letter lists side effects recorded during Haley's animal studies:

" soiling of the anogenital area, alopecia (hair loss) on the lower trunk, back

and legs, a dark substance on lower trunk and anogenital area, abnormalities of

the pancreas " and a rapid increase in normal cells contained in the lymph nodes.

>

> >

>

> > " It would be hard to imagine anything worse, " said Ellen Silbergeld, an

expert in environmental health who is studying mercury and autism at s

Hopkins University's Bloomberg School of Public Health. " An industrial chemical

known to be toxic †" his own incomplete testing indicates it is toxic. It has

no record of any therapeutic aspect of it, and it is being marketed for use in

children. "

>

> >

>

> > OSR#1 has been promoted on autism Web sites including Age of Autism, where

Managing Editor Kim Stagliano wrote of sprinkling the white powder on her three

daughters' breakfast sandwiches and orange juice. " We've seen some nice 'Wows!'

from OSR, " she wrote.

>

> >

>

> > In an e-mail, Stagliano wrote that she continues to support Haley, a regular

speaker at autism recovery conferences. " Having met Dr. Haley at conferences,

including Autism One in Chicago last month, I continue to trust his science, "

she wrote on Wednesday. " I'm sure CTI Science will address the letter

appropriately. "

>

> >

>

> > Pharmacologist Dr. Arthur Grollman, director of the Laboratory for Chemical

Biology at State University of New York at Stony Brook, said it is clear from

the product's chemical structure that it is a " powerful chelator, " a compound

that binds to heavy metals such as mercury.

>

> >

>

> > The FDA has approved several chelators as drugs to treat heavy-metal

poisoning. Some doctors also use the drugs †" which carry significant risks †"

to treat children with autism on the scientifically unfounded idea that their

disorder is linked to toxic metals.

>

> >

>

> > The chemical being sold as OSR#1 is part of a family of chelators originally

developed for industrial purposes, according to a U.S. patent issued in 2003 and

assigned to the University of Kentucky Research Foundation.

>

> >

>

> > The magazine Medical Veritas in 2006 reported that Haley said he was

interested in developing better chelators for people. " We've made compounds that

.... work tremendously " in a test tube, he was quoted as saying. " However, we've

got to show that they're not toxic. That costs a lot of money and it's very

difficult to do, you have to have the right facilities. That's where we're hung

up right now, the question is, 'How do we get somebody to do these studies?' "

>

> >

>

> > In January 2008, Haley changed the name of his company from Chelator

Technologies Inc. to CTI Science Inc., records show. Less than a month later, he

notified the FDA he would be introducing the compound as a new dietary

ingredient, a designation rejected by the FDA in its recent letter.

>

> >

>

> > " Because OSR#1 does not bear or contain a dietary ingredient as defined (by

the food and drug act), this product does not qualify as a dietary supplement, "

the letter states.

>

> >

>

> > Instead, according to the letter, it is a new drug. Winning FDA approval

requires proof of safety and efficacy through clinical trials, a process that

can cost hundreds of millions of dollars and take many years.

>

> >

>

> > " Anything might be a cure for anything else, but the odds are it will do

nothing and it might very well be toxic, " said Mailman, a

neuropharmacologist at Penn State University. " That is why drug discovery and

development is so expensive. "

>

> >

>

> > Silbergeld said the product represents a clear example of endangerment of

public health and that the FDA should stop CTI Science from selling it

immediately. She drew a comparison to a city's drinking water system: If

contamination is found, she said, " they turn off the pumps. "

>

> >

>

> > " They don't have to engage in a long discussion with you, " Silbergeld said.

" It would be hard to imagine a more clear example of immediate endangerment of

public health. Turn off the pump. "

>

> >

>

> > Copyright © 2010, Chicago Tribune

>

> >

>

>

[Guest guest]

I like that idea but unfortunately most autism parents have no idea what's going

on. Its all about the metals, toxins, etc.

>

>

>

> >

>

>

>

> > latimes.com/news/health/sns-health-illegal-autism-therapy,0,747838.story

>

>

>

> >

>

>

>

> > latimes.com

>

>

>

> > FDA: Autism 'Therapy' Illegal

>

>

>

> > OSR#1 is not a dietary supplement but a toxic, unapproved drug with serious

potential side effects, the U.S. Food and Drug Administration warns.

>

>

>

> > Trine Tsouderos

>

>

>

> >

>

>

>

> > Tribune reporter

>

>

>

> >

>

>

>

> > 5:18 PM PDT, June 23, 2010

>

>

>

> >

>

>

>

> > Advertisement

>

>

>

> >

>

>

>

> > A product promoted to parents of children with autism is not a harmless

dietary supplement, as claimed, but a toxic unapproved drug that lacks adequate

warnings about potential side effects, including hair loss and abnormalities of

the pancreas, the U.S. Food and Drug Administration has warned in a letter to

its maker.

>

>

>

> >

>

>

>

> > The FDA's June 17 letter to Boyd Haley, a retired Kentucky chemist and hero

to the autism recovery movement, details five violations of the Federal Food,

Drug and Cosmetic Act related to his product, OSR#1. Failing to correct such

violations can result in fines, seizure of products and even criminal

prosecution.

>

>

>

> >

>

>

>

> > The Tribune in January reported that the compound, sold as OSR#1, had been

developed to treat mining wastewater, and that it had not undergone rigorous

testing to ensure it is safe and effective. The report was part of an

investigation into unproven autism therapies offered by health providers who say

they can reverse the disorder.

>

>

>

> >

>

>

>

> > Haley did not reply to repeated requests for an interview Wednesday. An FDA

spokeswoman said the agency has not received any communication from Haley, who

has 15 working days from the date of the letter to respond.

>

>

>

> >

>

>

>

> > Last year, Haley told the Tribune: " I am not breaking any law. … We are

being very, very careful. "

>

>

>

> >

>

>

>

> > The Web site for Haley's company, Lexington, Ky.-based CTI Science, on

Wednesday was still promoting OSR#1 as " a toxicity free, lipid soluble

antioxidant dietary supplement, " and a reporter was able to order 30

100-milligram capsules of OSR#1 for $60 through an online pharmacy.

>

>

>

> >

>

>

>

> > In the interview last year, Haley called the product " a food " that is

" totally without toxicity. " Haley said the compound had been tested on rats, and

a food safety study was conducted on 10 people. Asked to provide documentation

of the research, he stopped communicating with the Tribune.

>

>

>

> >

>

>

>

> > The FDA letter lists side effects recorded during Haley's animal studies:

" soiling of the anogenital area, alopecia (hair loss) on the lower trunk, back

and legs, a dark substance on lower trunk and anogenital area, abnormalities of

the pancreas " and a rapid increase in normal cells contained in the lymph nodes.

>

>

>

> >

>

>

>

> > " It would be hard to imagine anything worse, " said Ellen Silbergeld, an

expert in environmental health who is studying mercury and autism at s

Hopkins University's Bloomberg School of Public Health. " An industrial chemical

known to be toxic †" his own incomplete testing indicates it is toxic. It has

no record of any therapeutic aspect of it, and it is being marketed for use in

children. "

>

>

>

> >

>

>

>

> > OSR#1 has been promoted on autism Web sites including Age of Autism, where

Managing Editor Kim Stagliano wrote of sprinkling the white powder on her three

daughters' breakfast sandwiches and orange juice. " We've seen some nice 'Wows!'

from OSR, " she wrote.

>

>

>

> >

>

>

>

> > In an e-mail, Stagliano wrote that she continues to support Haley, a regular

speaker at autism recovery conferences. " Having met Dr. Haley at conferences,

including Autism One in Chicago last month, I continue to trust his science, "

she wrote on Wednesday. " I'm sure CTI Science will address the letter

appropriately. "

>

>

>

> >

>

>

>

> > Pharmacologist Dr. Arthur Grollman, director of the Laboratory for Chemical

Biology at State University of New York at Stony Brook, said it is clear from

the product's chemical structure that it is a " powerful chelator, " a compound

that binds to heavy metals such as mercury.

>

>

>

> >

>

>

>

> > The FDA has approved several chelators as drugs to treat heavy-metal

poisoning. Some doctors also use the drugs †" which carry significant risks †"

to treat children with autism on the scientifically unfounded idea that their

disorder is linked to toxic metals.

>

>

>

> >

>

>

>

> > The chemical being sold as OSR#1 is part of a family of chelators originally

developed for industrial purposes, according to a U.S. patent issued in 2003 and

assigned to the University of Kentucky Research Foundation.

>

>

>

> >

>

>

>

> > The magazine Medical Veritas in 2006 reported that Haley said he was

interested in developing better chelators for people. " We've made compounds that

.... work tremendously " in a test tube, he was quoted as saying. " However, we've

got to show that they're not toxic. That costs a lot of money and it's very

difficult to do, you have to have the right facilities. That's where we're hung

up right now, the question is, 'How do we get somebody to do these studies?' "

>

>

>

> >

>

>

>

> > In January 2008, Haley changed the name of his company from Chelator

Technologies Inc. to CTI Science Inc., records show. Less than a month later, he

notified the FDA he would be introducing the compound as a new dietary

ingredient, a designation rejected by the FDA in its recent letter.

>

>

>

> >

>

>

>

> > " Because OSR#1 does not bear or contain a dietary ingredient as defined (by

the food and drug act), this product does not qualify as a dietary supplement, "

the letter states.

>

>

>

> >

>

>

>

> > Instead, according to the letter, it is a new drug. Winning FDA approval

requires proof of safety and efficacy through clinical trials, a process that

can cost hundreds of millions of dollars and take many years.

>

>

>

> >

>

>

>

> > " Anything might be a cure for anything else, but the odds are it will do

nothing and it might very well be toxic, " said Mailman, a

neuropharmacologist at Penn State University. " That is why drug discovery and

development is so expensive. "

>

>

>

> >

>

>

>

> > Silbergeld said the product represents a clear example of endangerment of

public health and that the FDA should stop CTI Science from selling it

immediately. She drew a comparison to a city's drinking water system: If

contamination is found, she said, " they turn off the pumps. "

>

>

>

> >

>

>

>

> > " They don't have to engage in a long discussion with you, " Silbergeld said.

" It would be hard to imagine a more clear example of immediate endangerment of

public health. Turn off the pump. "

>

>

>

> >

>

>

>

> > Copyright © 2010, Chicago Tribune

>

>

>

> >

>

>

>

>

[Guest guest]

I understand this, and I know that Trine Tsouderos takes facts and skews them

and this seems to be the case with OSR, too. However I do not believe that a

supplement such as this can get to the root of the problem our children with

autism have. I doubt any supplement can. I am not taking Trine's " side " but I

just think that supplements can hurt our kids too by aggravating their already

volatile and highly allergic immune systems.

-

> >

> > latimes.com/news/health/sns-health-illegal-autism-therapy,0,747838.story

> >

> > latimes.com

> > FDA: Autism 'Therapy' Illegal

> > OSR#1 is not a dietary supplement but a toxic, unapproved drug with serious

potential side effects, the U.S. Food and Drug Administration warns.

> > Trine Tsouderos

> >

> > Tribune reporter

> >

> > 5:18 PM PDT, June 23, 2010

> >

> > Advertisement

> >

> > A product promoted to parents of children with autism is not a harmless

dietary supplement, as claimed, but a toxic unapproved drug that lacks adequate

warnings about potential side effects, including hair loss and abnormalities of

the pancreas, the U.S. Food and Drug Administration has warned in a letter to

its maker.

> >

> > The FDA's June 17 letter to Boyd Haley, a retired Kentucky chemist and hero

to the autism recovery movement, details five violations of the Federal Food,

Drug and Cosmetic Act related to his product, OSR#1. Failing to correct such

violations can result in fines, seizure of products and even criminal

prosecution.

> >

> > The Tribune in January reported that the compound, sold as OSR#1, had been

developed to treat mining wastewater, and that it had not undergone rigorous

testing to ensure it is safe and effective. The report was part of an

investigation into unproven autism therapies offered by health providers who say

they can reverse the disorder.

> >

> > Haley did not reply to repeated requests for an interview Wednesday. An FDA

spokeswoman said the agency has not received any communication from Haley, who

has 15 working days from the date of the letter to respond.

> >

> > Last year, Haley told the Tribune: " I am not breaking any law. … We are

being very, very careful. "

> >

> > The Web site for Haley's company, Lexington, Ky.-based CTI Science, on

Wednesday was still promoting OSR#1 as " a toxicity free, lipid soluble

antioxidant dietary supplement, " and a reporter was able to order 30

100-milligram capsules of OSR#1 for $60 through an online pharmacy.

> >

> > In the interview last year, Haley called the product " a food " that is

" totally without toxicity. " Haley said the compound had been tested on rats, and

a food safety study was conducted on 10 people. Asked to provide documentation

of the research, he stopped communicating with the Tribune.

> >

> > The FDA letter lists side effects recorded during Haley's animal studies:

" soiling of the anogenital area, alopecia (hair loss) on the lower trunk, back

and legs, a dark substance on lower trunk and anogenital area, abnormalities of

the pancreas " and a rapid increase in normal cells contained in the lymph nodes.

> >

> > " It would be hard to imagine anything worse, " said Ellen Silbergeld, an

expert in environmental health who is studying mercury and autism at s

Hopkins University's Bloomberg School of Public Health. " An industrial chemical

known to be toxic †" his own incomplete testing indicates it is toxic. It has

no record of any therapeutic aspect of it, and it is being marketed for use in

children. "

> >

> > OSR#1 has been promoted on autism Web sites including Age of Autism, where

Managing Editor Kim Stagliano wrote of sprinkling the white powder on her three

daughters' breakfast sandwiches and orange juice. " We've seen some nice 'Wows!'

from OSR, " she wrote.

> >

> > In an e-mail, Stagliano wrote that she continues to support Haley, a regular

speaker at autism recovery conferences. " Having met Dr. Haley at conferences,

including Autism One in Chicago last month, I continue to trust his science, "

she wrote on Wednesday. " I'm sure CTI Science will address the letter

appropriately. "

> >

> > Pharmacologist Dr. Arthur Grollman, director of the Laboratory for Chemical

Biology at State University of New York at Stony Brook, said it is clear from

the product's chemical structure that it is a " powerful chelator, " a compound

that binds to heavy metals such as mercury.

> >

> > The FDA has approved several chelators as drugs to treat heavy-metal

poisoning. Some doctors also use the drugs †" which carry significant risks †"

to treat children with autism on the scientifically unfounded idea that their

disorder is linked to toxic metals.

> >

> > The chemical being sold as OSR#1 is part of a family of chelators originally

developed for industrial purposes, according to a U.S. patent issued in 2003 and

assigned to the University of Kentucky Research Foundation.

> >

> > The magazine Medical Veritas in 2006 reported that Haley said he was

interested in developing better chelators for people. " We've made compounds that

.... work tremendously " in a test tube, he was quoted as saying. " However, we've

got to show that they're not toxic. That costs a lot of money and it's very

difficult to do, you have to have the right facilities. That's where we're hung

up right now, the question is, 'How do we get somebody to do these studies?' "

> >

> > In January 2008, Haley changed the name of his company from Chelator

Technologies Inc. to CTI Science Inc., records show. Less than a month later, he

notified the FDA he would be introducing the compound as a new dietary

ingredient, a designation rejected by the FDA in its recent letter.

> >

> > " Because OSR#1 does not bear or contain a dietary ingredient as defined (by

the food and drug act), this product does not qualify as a dietary supplement, "

the letter states.

> >

> > Instead, according to the letter, it is a new drug. Winning FDA approval

requires proof of safety and efficacy through clinical trials, a process that

can cost hundreds of millions of dollars and take many years.

> >

> > " Anything might be a cure for anything else, but the odds are it will do

nothing and it might very well be toxic, " said Mailman, a

neuropharmacologist at Penn State University. " That is why drug discovery and

development is so expensive. "

> >

> > Silbergeld said the product represents a clear example of endangerment of

public health and that the FDA should stop CTI Science from selling it

immediately. She drew a comparison to a city's drinking water system: If

contamination is found, she said, " they turn off the pumps. "

> >

> > " They don't have to engage in a long discussion with you, " Silbergeld said.

" It would be hard to imagine a more clear example of immediate endangerment of

public health. Turn off the pump. "

> >

> > Copyright © 2010, Chicago Tribune

> >

>

>

>

>

>

>

>

>

[Guest guest]

This whole chat is an illustration of the problem we are facing as parents of

kids with " autism " . We are not doctors, but we have to figure out what is

medically right for our children without the support of mainstream medicine.

I for one will admit that what I did to my son by putting him through chelation

and questionable supplements (in retrospect) is AWFUL, but it was done out of

the sincere desire for him to he healthy and happy. Its a horrible place for any

parent to be in, I feel shame about what I did. i thought I was doing the right

thing, but the truth is I was in such a place of despair that I wasn't making

sound decisions. And when this happen to you kid, it is almost impossible to

think straight. It took me 2 years to stop deluding myself and start asking

logical, scientific questions. When I did, all things pointed to .

Without the support of mainstream medicine, lots of these kids are going to fall

victim to someone trying to make a buck. In no way do I think everyone out there

is trying to harm your kids, and Boyd Haley is probably not a bad person... but

there is NO system of checks and balances... its the wild west out there and

plenty of well meaning people are going to do stupid things.

> >

> > latimes.com/news/health/sns-health-illegal-autism-therapy,0,747838.story

> >

> > latimes.com

> > FDA: Autism 'Therapy' Illegal

> > OSR#1 is not a dietary supplement but a toxic, unapproved drug with serious

potential side effects, the U.S. Food and Drug Administration warns.

> > Trine Tsouderos

> >

> > Tribune reporter

> >

> > 5:18 PM PDT, June 23, 2010

> >

> > Advertisement

> >

> > A product promoted to parents of children with autism is not a harmless

dietary supplement, as claimed, but a toxic unapproved drug that lacks adequate

warnings about potential side effects, including hair loss and abnormalities of

the pancreas, the U.S. Food and Drug Administration has warned in a letter to

its maker.

> >

> > The FDA's June 17 letter to Boyd Haley, a retired Kentucky chemist and hero

to the autism recovery movement, details five violations of the Federal Food,

Drug and Cosmetic Act related to his product, OSR#1. Failing to correct such

violations can result in fines, seizure of products and even criminal

prosecution.

> >

> > The Tribune in January reported that the compound, sold as OSR#1, had been

developed to treat mining wastewater, and that it had not undergone rigorous

testing to ensure it is safe and effective. The report was part of an

investigation into unproven autism therapies offered by health providers who say

they can reverse the disorder.

> >

> > Haley did not reply to repeated requests for an interview Wednesday. An FDA

spokeswoman said the agency has not received any communication from Haley, who

has 15 working days from the date of the letter to respond.

> >

> > Last year, Haley told the Tribune: " I am not breaking any law. … We are

being very, very careful. "

> >

> > The Web site for Haley's company, Lexington, Ky.-based CTI Science, on

Wednesday was still promoting OSR#1 as " a toxicity free, lipid soluble

antioxidant dietary supplement, " and a reporter was able to order 30

100-milligram capsules of OSR#1 for $60 through an online pharmacy.

> >

> > In the interview last year, Haley called the product " a food " that is

" totally without toxicity. " Haley said the compound had been tested on rats, and

a food safety study was conducted on 10 people. Asked to provide documentation

of the research, he stopped communicating with the Tribune.

> >

> > The FDA letter lists side effects recorded during Haley's animal studies:

" soiling of the anogenital area, alopecia (hair loss) on the lower trunk, back

and legs, a dark substance on lower trunk and anogenital area, abnormalities of

the pancreas " and a rapid increase in normal cells contained in the lymph nodes.

> >

> > " It would be hard to imagine anything worse, " said Ellen Silbergeld, an

expert in environmental health who is studying mercury and autism at s

Hopkins University's Bloomberg School of Public Health. " An industrial chemical

known to be toxic †" his own incomplete testing indicates it is toxic. It has

no record of any therapeutic aspect of it, and it is being marketed for use in

children. "

> >

> > OSR#1 has been promoted on autism Web sites including Age of Autism, where

Managing Editor Kim Stagliano wrote of sprinkling the white powder on her three

daughters' breakfast sandwiches and orange juice. " We've seen some nice 'Wows!'

from OSR, " she wrote.

> >

> > In an e-mail, Stagliano wrote that she continues to support Haley, a regular

speaker at autism recovery conferences. " Having met Dr. Haley at conferences,

including Autism One in Chicago last month, I continue to trust his science, "

she wrote on Wednesday. " I'm sure CTI Science will address the letter

appropriately. "

> >

> > Pharmacologist Dr. Arthur Grollman, director of the Laboratory for Chemical

Biology at State University of New York at Stony Brook, said it is clear from

the product's chemical structure that it is a " powerful chelator, " a compound

that binds to heavy metals such as mercury.

> >

> > The FDA has approved several chelators as drugs to treat heavy-metal

poisoning. Some doctors also use the drugs †" which carry significant risks †"

to treat children with autism on the scientifically unfounded idea that their

disorder is linked to toxic metals.

> >

> > The chemical being sold as OSR#1 is part of a family of chelators originally

developed for industrial purposes, according to a U.S. patent issued in 2003 and

assigned to the University of Kentucky Research Foundation.

> >

> > The magazine Medical Veritas in 2006 reported that Haley said he was

interested in developing better chelators for people. " We've made compounds that

.... work tremendously " in a test tube, he was quoted as saying. " However, we've

got to show that they're not toxic. That costs a lot of money and it's very

difficult to do, you have to have the right facilities. That's where we're hung

up right now, the question is, 'How do we get somebody to do these studies?' "

> >

> > In January 2008, Haley changed the name of his company from Chelator

Technologies Inc. to CTI Science Inc., records show. Less than a month later, he

notified the FDA he would be introducing the compound as a new dietary

ingredient, a designation rejected by the FDA in its recent letter.

> >

> > " Because OSR#1 does not bear or contain a dietary ingredient as defined (by

the food and drug act), this product does not qualify as a dietary supplement, "

the letter states.

> >

> > Instead, according to the letter, it is a new drug. Winning FDA approval

requires proof of safety and efficacy through clinical trials, a process that

can cost hundreds of millions of dollars and take many years.

> >

> > " Anything might be a cure for anything else, but the odds are it will do

nothing and it might very well be toxic, " said Mailman, a

neuropharmacologist at Penn State University. " That is why drug discovery and

development is so expensive. "

> >

> > Silbergeld said the product represents a clear example of endangerment of

public health and that the FDA should stop CTI Science from selling it

immediately. She drew a comparison to a city's drinking water system: If

contamination is found, she said, " they turn off the pumps. "

> >

> > " They don't have to engage in a long discussion with you, " Silbergeld said.

" It would be hard to imagine a more clear example of immediate endangerment of

public health. Turn off the pump. "

> >

> > Copyright © 2010, Chicago Tribune

> >

>

>

[Guest guest]

> >

> > latimes.com/news/health/sns-health-illegal-autism-therapy,0,747838.story

> >

> > latimes.com

> > FDA: Autism 'Therapy' Illegal

> > OSR#1 is not a dietary supplement but a toxic, unapproved drug with serious

potential side effects, the U.S. Food and Drug Administration warns.

> > Trine Tsouderos

> >

> > Tribune reporter

> >

> > 5:18 PM PDT, June 23, 2010

> >

> > Advertisement

> >

> > A product promoted to parents of children with autism is not a harmless

dietary supplement, as claimed, but a toxic unapproved drug that lacks adequate

warnings about potential side effects, including hair loss and abnormalities of

the pancreas, the U.S. Food and Drug Administration has warned in a letter to

its maker.

> >

> > The FDA's June 17 letter to Boyd Haley, a retired Kentucky chemist and hero

to the autism recovery movement, details five violations of the Federal Food,

Drug and Cosmetic Act related to his product, OSR#1. Failing to correct such

violations can result in fines, seizure of products and even criminal

prosecution.

> >

> > The Tribune in January reported that the compound, sold as OSR#1, had been

developed to treat mining wastewater, and that it had not undergone rigorous

testing to ensure it is safe and effective. The report was part of an

investigation into unproven autism therapies offered by health providers who say

they can reverse the disorder.

> >

> > Haley did not reply to repeated requests for an interview Wednesday. An FDA

spokeswoman said the agency has not received any communication from Haley, who

has 15 working days from the date of the letter to respond.

> >

> > Last year, Haley told the Tribune: " I am not breaking any law. … We are

being very, very careful. "

> >

> > The Web site for Haley's company, Lexington, Ky.-based CTI Science, on

Wednesday was still promoting OSR#1 as " a toxicity free, lipid soluble

antioxidant dietary supplement, " and a reporter was able to order 30

100-milligram capsules of OSR#1 for $60 through an online pharmacy.

> >

> > In the interview last year, Haley called the product " a food " that is

" totally without toxicity. " Haley said the compound had been tested on rats, and

a food safety study was conducted on 10 people. Asked to provide documentation

of the research, he stopped communicating with the Tribune.

> >

> > The FDA letter lists side effects recorded during Haley's animal studies:

" soiling of the anogenital area, alopecia (hair loss) on the lower trunk, back

and legs, a dark substance on lower trunk and anogenital area, abnormalities of

the pancreas " and a rapid increase in normal cells contained in the lymph nodes.

> >

> > " It would be hard to imagine anything worse, " said Ellen Silbergeld, an

expert in environmental health who is studying mercury and autism at s

Hopkins University's Bloomberg School of Public Health. " An industrial chemical

known to be toxic — his own incomplete testing indicates it is toxic. It has no

record of any therapeutic aspect of it, and it is being marketed for use in

children. "

> >

> > OSR#1 has been promoted on autism Web sites including Age of Autism, where

Managing Editor Kim Stagliano wrote of sprinkling the white powder on her three

daughters' breakfast sandwiches and orange juice. " We've seen some nice 'Wows!'

from OSR, " she wrote.

> >

> > In an e-mail, Stagliano wrote that she continues to support Haley, a regular

speaker at autism recovery conferences. " Having met Dr. Haley at conferences,

including Autism One in Chicago last month, I continue to trust his science, "

she wrote on Wednesday. " I'm sure CTI Science will address the letter

appropriately. "

> >

> > Pharmacologist Dr. Arthur Grollman, director of the Laboratory for Chemical

Biology at State University of New York at Stony Brook, said it is clear from

the product's chemical structure that it is a " powerful chelator, " a compound

that binds to heavy metals such as mercury.

> >

> > The FDA has approved several chelators as drugs to treat heavy-metal

poisoning. Some doctors also use the drugs — which carry significant risks — to

treat children with autism on the scientifically unfounded idea that their

disorder is linked to toxic metals.

> >

> > The chemical being sold as OSR#1 is part of a family of chelators originally

developed for industrial purposes, according to a U.S. patent issued in 2003 and

assigned to the University of Kentucky Research Foundation.

> >

> > The magazine Medical Veritas in 2006 reported that Haley said he was

interested in developing better chelators for people. " We've made compounds that

.... work tremendously " in a test tube, he was quoted as saying. " However, we've

got to show that they're not toxic. That costs a lot of money and it's very

difficult to do, you have to have the right facilities. That's where we're hung

up right now, the question is, 'How do we get somebody to do these studies?' "

> >

> > In January 2008, Haley changed the name of his company from Chelator

Technologies Inc. to CTI Science Inc., records show. Less than a month later, he

notified the FDA he would be introducing the compound as a new dietary

ingredient, a designation rejected by the FDA in its recent letter.

> >

> > " Because OSR#1 does not bear or contain a dietary ingredient as defined (by

the food and drug act), this product does not qualify as a dietary supplement, "

the letter states.

> >

> > Instead, according to the letter, it is a new drug. Winning FDA approval

requires proof of safety and efficacy through clinical trials, a process that

can cost hundreds of millions of dollars and take many years.

> >

> > " Anything might be a cure for anything else, but the odds are it will do

nothing and it might very well be toxic, " said Mailman, a

neuropharmacologist at Penn State University. " That is why drug discovery and

development is so expensive. "

> >

> > Silbergeld said the product represents a clear example of endangerment of

public health and that the FDA should stop CTI Science from selling it

immediately. She drew a comparison to a city's drinking water system: If

contamination is found, she said, " they turn off the pumps. "

> >

> > " They don't have to engage in a long discussion with you, " Silbergeld said.

" It would be hard to imagine a more clear example of immediate endangerment of

public health. Turn off the pump. "

> >

> > , Chicago Tribune

> >

>We did the vitamin & chelation( very little) thinking it was metals You

desperatly want to help your child get better. Our child got only sicker I thank

God we are doing what is right for him now. I agree with Sloan it is the Wild

West out there.

Carole